DNA Microarray Market

Next-generation Sequencing Takes DNA Microarrays Head on

The DNA Microarray Market is valued at USD 2.8 Bn in 2026 and is projected to reach USD 5.9 Bn,  growing at a CAGR of 11% by 2033.The capability of DNA microarrays to conduct a comprehensive, and concurrent analysis of thousands of genes has resulted in the success of this technology in the last decade. Technological progression in computational capabilities, and robotics for microarray procedures have steered the rapid uptake of gene chips in clinical laboratories worldwide. Vendors are striving to develop innovative solutions for storage and analysis of microarray-generated information to facilitate biomedicine applications of the array technology. This will remain the key driving force behind DNA microarray market growth.

The DNA and gene chip industry is principally driven by a recent evolution in the areas of personalized medicine and cancer diagnostics. Many companies developing microarray technologies are catering to a vast majority of public institutes which include government laboratories, academic centres, and clinical research organizations. Though the popularity of Next Generation Sequencing (NGS) has skyrocketed recently, it is not completely replacing microarrays in diagnostics, and cytogenetics due to its relatively high price, and sturdy rate of clinical implementation.

Early Cancer Diagnosis Requirement is Driving Global DNA Microarray Market

Consumables captured the largest share in the DNA microarray market in 2019 and this product segment is anticipated to hold the lion’s share during the forecast period. This growth is primarily on the account of technological advancements in gene expression analysis algorithms, together with ease of availability of reagents and other auxiliary components required for microarray procedures.

Cancer diagnosis and treatment was the dominant application in 2019 due to incremental demand for targeted cancer therapies. Drug discovery has set the ground to become fastest-growing application segment due to strong demand of genomic chip arrays for optimization for different drug discovery processes such as disease pathway identification, disease pathway validation, and compound screening.

Academic and government research institutes accounted for the largest share in DNA microarray market in 2019. The segment is also expected to dominate the market till the end of the forecast period, 2025. Many government institutes are spending heavily on R&D activities. Multiple research projects are taking place in a wide range of applications.

Companies to Set up Plants in Asia Pacific Region to Expand Regional Footprints

North America is the leading region as it is home to well-established players, innovative informatics infrastructure hub, and large-scale genomic R&D projects in the region. On the other hand, Asia Pacific is expected to register the highest CAGR over the forecast period as there is growing awareness regarding genetic tests for disease risk assessment, and prevention. Asia Pacific will offer a massive growth prospect to DNA microarray market as the region boasts a high population base and the substantial budget allocations by governments in developing countries towards the biotechnology sector. Affymetrix, Inc (U.S.) and Illumina, Inc. (U.S.) have established their manufacturing facilities in the Asian sub-continent to take benefit from the growing demand and gain a competitive edge in the region.

Competitive Analysis

• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• PerkinElmer, Inc.
• Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
• QIAGEN N.V.
• Arrayit Corporation
• Oxford Gene Technology
• Applied Microarrays, Inc.
• Molecular Devices LLC
• Macrogen, Inc.
• CapitalBio Corporation
• Eurofins Genomics LLC

The DNA microarray market is segmented as below:

By Type

• Oligonucleotide DNA Microarrays
• Complementary DNA Microarrays

By Application  

• Gene Expression Analysis
• Transcription Factor Binding Analysis
• Genotyping
• Others

By End-User      

• Biotechnology & Pharmaceutical Industries
• Diagnostic Centers
• Hospitals & Clinics
• Academic & Research Institutes
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa